OSELTAMIVIR PHOSPHATE
NDC 70710-1165, oseltamivir phosphate, for suspension, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1165
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209113
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1165-6 | 70710116506 | 1 BOTTLE in 1 CARTON (70710-1165-6) / 60 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/432d9e7b-9cb2-4b7d-9fb2-015449096757NADAC price for package 70710116506
GET /v1/drugs/nadac/70710116506
Use it
Look up 70710-1165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.